Showing results (631-640 of 824) with videos related to
Sort By:
Pageof 83
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 29, 2015
Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group studyGianni Allais, Gennaro Bussone, Vincenzo Tullo, et al.Nature|December 16, 2006
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreakTulio de Oliveira, Oliver G Pybus, Andrew Rambaut, et al.Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|May 21, 2009
Assessment of the initial stability of the Symax femoral stem with EBRA-FCA: a multicentric study of 85 casesCarlo Alberto Buratti, Carmelo D'Arrigo, Giulio Guido, et al.Journal of Virology|July 30, 2005
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutationsFrancesca Ceccherini-Silberstein, Federico Gago, Maria Santoro, et al.AIDS (London, England)|July 29, 2004
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressureFrancesca Ceccherini-Silberstein, Fulvio Erba, Federico Gago, et al.Cancer Research|April 19, 2005
Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoterSonia A Lee, Daniel Ndisang, Chandrakant Patel, et al.Journal of the Neurological Sciences|May 5, 2012
Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain diseaseS Saredi, A Ardissone, A Ruggieri, et al.European Journal of Haematology|July 9, 2026
Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized CareEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.Oncotarget|October 6, 2017
A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in gliomaPaolo D'Arrigo, Michele Russo, Anna Rea, et al.The Journal of Pharmacology and Experimental Therapeutics|September 27, 2007
1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicityBruno P Imbimbo, Elda Del Giudice, Davide Colavito, et al.Pageof 83